Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $2,023+, returning 11,988.3%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 11,988.32% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 2,867.14% |
DeFi Development (DFDV) | 2,310.46% |
WW International, Inc Common Stock (WW) | 1,895.42% |
Zepp Health (ZEPP) | 1,808.85% |
Abits (ABTS) | 1,473.67% |
FiEE (FIEE) | 1,202.75% |
Abivax SA American Depositary Shares (ABVX) | 1,044.61% |
Oncology Institute (TOI) | 1,024.18% |
Lizhi (SOGP) | 904.11% |
Global Interactive Technologies (GITS) | 846.06% |
Nova Lifestyle I (NVFY) | 732.07% |
Dominari (DOMH) | 639.56% |
Airnet Technology (ANTE) | 627.88% |
mF International Limited Ordinary Shares (MFI) | 600.24% |
Nanobiotix (NBTX) | 539.23% |
ThredUp (TDUP) | 534.72% |
Better Home & Finance (BETR) | 524.69% |
TMC the metals (TMC) | 524.56% |
M3-Brigade Acquisition V Corp Warrant (MBAVW) | 523.69% |
Eightco (OCTO) | 514.9% |
Oklo (OKLO) | 506.69% |
Lixte Biotechnology (LIXTW) | 500% |
Mobilicom Limited Warrants (MOBBW) | 494.72% |
